NanOZ LNP-saRNA GFP
saRNA encoding eGFP formulated in lipid nanoparticles
NanOZ LNP-saRNA GFP is a ready-to-use self-amplifying RNA (saRNA) encoding eGFP, encapsulated in lipid nanoparticles (LNPs) produced by microfluidic technology.
The LNPs are monodisperse, with a narrow size distribution and a high encapsulation efficiency (>80%). They are designed to protect the saRNA from degradation and to facilitate its intracellular uptake. Transfection efficiency and expression kinetics can be assessed by measuring the fluorescent signal.
The saRNA is unmodified, capped at the 5' end (Cap1) and contains a poly(A) tail at the 3' end.
Concentration: 0.1 mg/mL (100 µg/mL) saRNA in LNPs
Buffer: PBS, 10% sucrose
Sizes:
- LNPSA10500: 0.5 mL (2 x 250 µL)
- LNPSA11000: 1 mL (4 x 250 µL)
- LNPSA15000: 5 mL (20 x 250 µL)
Storage: -80°C. We recommend minimizing freeze-thaw cycles to preserve LNP integrity.
Shipping: Dry ice (dry ice fee included in shipping cost).
This product is manufactured "on demand", which means that no stock is produced, so the expected delivery time is 2 to 3 weeks.
| Catalog number | Unit Size | Price excl tax | Quantity / Buy |
| LNPSA10500 |
0.5 mL (2 × 250 µL) of saRNA-LNP, 50 µg of eGFP saRNA
|
$900.00
|
|
| LNPSA11000 |
1 mL (4 × 250 µL) of saRNA-LNP, 100 µg of eGFP saRNA
|
$1,582.00
|
|
| LNPSA15000 |
5 mL (20 × 250 µL) of saRNA-LNP, 500 µg of eGFP saRNA
|
$6,076.00
|
|
Citation database
Related products
GFP saRNA
Reporter Gene saRNA
Unmodified / m5C
NanOZ LNP-saRNA FLuc
NanOZ LNP-saRNA
saRNA encoding FLuc formulated in lipid nanoparticles
NanOZ LNP-saRNA OVA
NanOZ LNP-saRNA
saRNA encoding OVA formulated in lipid nanoparticles